US stock · Technology sector · Scientific & Technical Instruments
Company Logo

Fortive Corporation

FTVNYSE

65.43

USD
+1.50
(+2.35%)
Market Closed
31.34P/E
18Forward P/E
1.48P/E to S&P500
23.110BMarket CAP
0.44%Div Yield
Upcoming Earnings
26 Apr-1 May
Shares Short
2/28/23
4.54M
Short % of Float
1.44%
Short % of Shares Outs.
1.28%
% Held by Insiders
1.50%
% Held by Institutions
96.28%
Beta
1.17
PEG Ratio
2.57
52w. high/low
69.78/52.47
Avg. Daily Volume
1.75M
Return %
Stock
S&P 500
1 year
3.87
(11.55)
3 years
67.01
64.96
5 years
(2.22)
44.15
Scale: |
High
Low
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
47.06
38.74
63.34
44.34
73.92
52.63
74.88
53.15
74.25
31.22
79.87
64.58
76.53
52.47
69.78
63.01
Currency: USD
- -
- -
- -
- -
- -
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Revenue per share
- -
- -
- -
- -
- -
16.76
17.27
18.36
17.70
18.00
19.15
18.68
21.80
13.74
15.06
16.69
Earnings per share
- -
- -
- -
- -
- -
2.21
2.41
2.56
2.47
2.52
3.01
8.43
2.20
4.78
1.74
2.16
FCF per share
- -
- -
- -
- -
- -
2.53
2.75
2.45
2.55
2.91
2.99
3.57
3.45
4.03
2.61
3.46
Dividends per share
- -
- -
- -
- -
- -
- -
- -
- -
- -
8.82
0.28
0.38
0.48
0.48
0.38
0.29
CAPEX per share
- -
- -
- -
- -
- -
0.20
0.23
0.30
0.34
0.37
0.39
0.33
0.34
0.22
0.14
0.27
Book Value per sh.
- -
- -
- -
- -
- -
- -
14.84
15.15
14.84
7.78
10.91
19.09
22.00
26.57
27.26
27.75
Comm.Shares outs.
- -
- -
- -
- -
- -
345
345
345
349
346
348
346
336
337
349
349
Avg. annual P/E ratio
- -
- -
- -
- -
- -
- -
- -
- -
- -
17.1
18.0
7.6
28.7
12.4
41.2
29.1
P/E to S&P500
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.8
0.8
0.3
1.2
0.3
1.4
1.4
Avg. annual div. yield
- -
- -
- -
- -
- -
- -
- -
- -
- -
20.5%
0.5%
0.6%
0.8%
0.8%
0.5%
0.5%
Revenue (m)
- -
- -
- -
- -
- -
5,785
5,962
6,337
6,179
6,224
6,656
6,453
7,320
4,634
5,255
5,826
Operating margin
- -
- -
- -
- -
- -
19.5%
19.2%
19.7%
20.5%
20.0%
20.4%
18.3%
13.7%
11.6%
15.5%
16.9%
Depreciation (m)
- -
- -
- -
- -
- -
145
160
178
177
176
174
261
426
384
396
466
Net profit (m)
- -
- -
- -
- -
- -
764
831
883
864
872
1,045
2,914
739
1,613
608
755
Income tax rate
- -
- -
- -
- -
- -
32.3%
27.3%
30.9%
32.0%
27.1%
18.7%
14.8%
17.0%
3.7%
9.3%
13.5%
Net profit margin
- -
- -
- -
- -
- -
13.2%
13.9%
13.9%
14.0%
14.0%
15.7%
45.2%
10.1%
34.8%
11.6%
13.0%
Working capital (m)
- -
- -
- -
- -
- -
- -
378
398
271
1,022
1,335
979
222
1,586
(1,200)
(250)
Long-term debt (m)
- -
- -
- -
- -
- -
- -
- -
- -
- -
3,358
4,056
2,975
4,987
2,985
1,947
2,252
Equity (m)
- -
- -
- -
- -
- -
- -
5,123
5,229
5,180
2,688
3,790
6,596
7,387
8,964
9,512
9,683
ROIC
- -
- -
- -
- -
- -
- -
13.9%
14.6%
14.7%
13.5%
12.5%
25.2%
4.3%
13.3%
5.5%
6.4%
Return on capital
- -
- -
- -
- -
- -
- -
15.8%
17.4%
17.6%
15.2%
13.1%
24.6%
4.2%
11.3%
4.7%
6.1%
Return on equity
- -
- -
- -
- -
- -
- -
16.2%
16.9%
16.7%
32.5%
27.6%
44.2%
10.0%
18.0%
6.4%
7.8%
Plowback ratio
- -
- -
- -
- -
- -
100.0%
100.0%
100.0%
100.0%
(249.5)%
90.7%
85.7%
77.6%
88.7%
78.5%
86.8%
Div.&Repurch./FCF
- -
- -
- -
- -
- -
- -
- -
- -
- -
302.6%
9.3%
10.7%
14.0%
12.0%
14.5%
44.9%
Capital Structure
28 Feb · 2023 | Q4
All numbers in millions
Total liabilities
$ 6,207
Total assets
$ 15,891
Long-term debt
$ 2,252
Cash and equiv.
$ 709
Goodwill
$ 9,049
Retained earnings
$ 6,742
Common stock
355
Enterprise Value
$ 24,652
Working Capital
Currency: USD, in millions
2020
2021
2022
Cash & Investments
2,944
819
709
Receivables
810
930
959
Inventory
456
513
537
Other
237
(753)
(843)
Current assets
4,447
2,515
2,477
Acc. Payable
481
558
623
Debt due
1,447
2,196
1,000
Other
933
961
1,104
Current liabilities
2,861
3,715
2,727
Annual growth rates
(avg. rate of change)
1 year
5 years
10 years
Revenue
10.87%
0.25%
1.05%
Cash flow
32.52%
2.74%
4.47%
Earnings
24.13%
1.38%
23.26%
Dividends
(24.74)%
(4.91)%
- -
Book value
1.80%
10.32%
12.14%
Insider Trading
Type
Shares
Date
Underwood Peter C
Award
1,034
03/15/23
Lico James A
Award
5,631
03/15/23
Mulhall Christopher M.
Award
713
03/15/23
Soroye Olumide
Award
1,747
03/15/23
Newcombe Tamara S.
Award
1,018
03/15/23
Quarterly Revenue
Currency: USD, in millions
Year
1Q
2Q
3Q
4Q
Total
2020
1,714
1,571
1,902
(553)
4,634
2021
1,259
1,320
1,300
1,376
5,255
2022
1,377
1,463
1,456
1,530
5,826
Earnings per share
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2020
0.12
0.39
0.67
3.60
4.78
2021
0.32
0.52
0.43
0.48
1.74
2022
0.47
0.50
0.54
0.65
2.16
Quarterly dividends paid
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2020
0.07
0.12
0.12
0.17
0.48
2021
0.12
0.12
0.07
0.07
0.38
2022
0.07
0.07
0.07
0.07
0.29
Company Description
Sector:
Technology
Industry:
Scientific & Technical Instruments
CEO:
Mr. James A. Lico
Full-time employees:
18,000
City:
Everett
Address:
6920 Seaway Boulevard
IPO:
Jun 13, 2016
Website:
Fortive Corporation designs, develops, manufactures, markets, and services professional and engineered products, software, and services worldwide. Its Intelligent Operating Solutions segment offers connected reliability tools; environment, health, safety, and quality enterprise software products; facility and asset lifecycle software; pre-construction planning and construction procurement solutions; ruggedized professional test tools; electric, pressure, and temperature calibration tools; and portable gas detection tools for a range of vertical end markets including manufacturing, process industries, healthcare, utilities and power, communications and electronics, and others. It markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL brands. The company's Precision Technologies segment provides electrical test and measurement instruments and services; energetic material devices; and sensor and control system solutions for power and energy, medical equipment, food and beverage, aerospace and defense, off-highway vehicles, electronics, semiconductors, and other general industrial markets. This segment markets its products under the ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, and TEKTRONIX brands. Its Advanced Healthcare Solutions segment offers hardware and software products and services, including instrument and device reprocessing, instrument tracking, biomedical test tools, radiation safety monitoring, and asset management services; subscription-based surgical inventory management systems to facilitate inventory management and regulatory compliance, as well as technical, analytical, and compliance services to determine radiation exposure services under the ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, RAYSAFE, and STERRAD brands. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.
Recent News